← Back to headlines
Germany's Merck Expands Life Sciences with $11.3B Bio-Techne Acquisition
German pharmaceutical and chemical company Merck has announced an $11.3 billion deal to acquire Bio-Techne, significantly boosting its life sciences business. This acquisition aims to strengthen Merck's position in the biotechnology sector.
26 Jun, 04:01 — 26 Jun, 04:01
Sources
Showing 1 of 1 sources
